FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2565328088> ?p ?o ?g. }

• W2565328088 endingPage "848" @default.
• W2565328088 startingPage "841" @default.
• W2565328088 abstract "Antioxidants induce the proliferation of cancers by decreasing the expression of p53. Propofol, one of the most extensively used intravenous anesthetics, provides its antioxidative activity via activation of the nuclear factor E2-related factor-2 (Nrf2) pathway, but the mechanisms involved in the effects remain unknown. Thus, we aimed to investigate the function of p53 and Nrf2 in the human breast cancer cell line MDA-MB-231 following treatment with propofol. The cells were treated with propofol (2, 5 and 10 µg/ml) for 1, 4 and 12 h, and MTT assay was used to evaluate cell proliferation, and a wound healing assay was used to evaluate cell migration. Cell apoptosis, caspase-3 activity, and western blot analysis for p53 and Nrf2 protein were also assessed. Finally, PIK-75, a potent Nrf2 inhibitor, was used to confirm the effects of Nrf2 after treatment with propofol. Treatment of MDA-MB‑231 cells with propofol resulted in increased proliferation and migration in a dose- and time-dependent manner. After treatment with propofol for 12 h, the Nrf2 protein expression was increased, while the percentage of apoptotic cells, caspase-3 activity, and expression of p53 were significantly decreased. Additionally, treatment with the Nrf2 inhibitor increased the percentage of apoptotic cells, inhibited the migration almost completely, and decreased the degree of proliferation, while the expression of p53 was not affected. In conclusion, propofol increased the proliferation of human breast cancer MDA-MB‑231 cells, which was at least partially associated with the inhibition of the expression of p53, and induced cell migration, which was involved in the activation of the Nrf2 pathway." @default.
• W2565328088 created "2017-01-06" @default.
• W2565328088 creator A5006721216 @default.
• W2565328088 creator A5018892762 @default.
• W2565328088 creator A5021752634 @default.
• W2565328088 creator A5040801000 @default.
• W2565328088 creator A5045705855 @default.
• W2565328088 creator A5066953470 @default.
• W2565328088 date "2016-12-23" @default.
• W2565328088 modified "2023-10-16" @default.
• W2565328088 title "Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231" @default.
• W2565328088 cites W1527114747 @default.
• W2565328088 cites W1972625598 @default.
• W2565328088 cites W1991265255 @default.
• W2565328088 cites W1996227056 @default.
• W2565328088 cites W1999852701 @default.
• W2565328088 cites W2013131201 @default.
• W2565328088 cites W2023373433 @default.
• W2565328088 cites W2029684007 @default.
• W2565328088 cites W2037199501 @default.
• W2565328088 cites W2049338354 @default.
• W2565328088 cites W2056956348 @default.
• W2565328088 cites W2060719597 @default.
• W2565328088 cites W2067273088 @default.
• W2565328088 cites W2068102724 @default.
• W2565328088 cites W2072715976 @default.
• W2565328088 cites W2086540027 @default.
• W2565328088 cites W2086764184 @default.
• W2565328088 cites W2087996967 @default.
• W2565328088 cites W2099113454 @default.
• W2565328088 cites W2106009044 @default.
• W2565328088 cites W2112161183 @default.
• W2565328088 cites W2114194406 @default.
• W2565328088 cites W2121544816 @default.
• W2565328088 cites W2136638122 @default.
• W2565328088 cites W2138271341 @default.
• W2565328088 cites W2143368626 @default.
• W2565328088 cites W2154553542 @default.
• W2565328088 cites W2162132388 @default.
• W2565328088 cites W2168520553 @default.
• W2565328088 cites W2170101247 @default.
• W2565328088 doi "https://doi.org/10.3892/or.2016.5332" @default.
• W2565328088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28035403" @default.
• W2565328088 hasPublicationYear "2016" @default.
• W2565328088 type Work @default.
• W2565328088 sameAs 2565328088 @default.
• W2565328088 citedByCount "52" @default.
• W2565328088 countsByYear W25653280882017 @default.
• W2565328088 countsByYear W25653280882018 @default.
• W2565328088 countsByYear W25653280882019 @default.
• W2565328088 countsByYear W25653280882020 @default.
• W2565328088 countsByYear W25653280882021 @default.
• W2565328088 countsByYear W25653280882022 @default.
• W2565328088 countsByYear W25653280882023 @default.
• W2565328088 crossrefType "journal-article" @default.
• W2565328088 hasAuthorship W2565328088A5006721216 @default.
• W2565328088 hasAuthorship W2565328088A5018892762 @default.
• W2565328088 hasAuthorship W2565328088A5021752634 @default.
• W2565328088 hasAuthorship W2565328088A5040801000 @default.
• W2565328088 hasAuthorship W2565328088A5045705855 @default.
• W2565328088 hasAuthorship W2565328088A5066953470 @default.
• W2565328088 hasBestOaLocation W25653280881 @default.
• W2565328088 hasConcept C104317684 @default.
• W2565328088 hasConcept C121608353 @default.
• W2565328088 hasConcept C126322002 @default.
• W2565328088 hasConcept C127561419 @default.
• W2565328088 hasConcept C137738243 @default.
• W2565328088 hasConcept C1491633281 @default.
• W2565328088 hasConcept C185592680 @default.
• W2565328088 hasConcept C190283241 @default.
• W2565328088 hasConcept C2776277131 @default.
• W2565328088 hasConcept C2776415932 @default.
• W2565328088 hasConcept C2780783641 @default.
• W2565328088 hasConcept C2781018059 @default.
• W2565328088 hasConcept C29537977 @default.
• W2565328088 hasConcept C502942594 @default.
• W2565328088 hasConcept C54355233 @default.
• W2565328088 hasConcept C55493867 @default.
• W2565328088 hasConcept C62112901 @default.
• W2565328088 hasConcept C71924100 @default.
• W2565328088 hasConcept C81885089 @default.
• W2565328088 hasConcept C86803240 @default.
• W2565328088 hasConcept C96232424 @default.
• W2565328088 hasConcept C98274493 @default.
• W2565328088 hasConceptScore W2565328088C104317684 @default.
• W2565328088 hasConceptScore W2565328088C121608353 @default.
• W2565328088 hasConceptScore W2565328088C126322002 @default.
• W2565328088 hasConceptScore W2565328088C127561419 @default.
• W2565328088 hasConceptScore W2565328088C137738243 @default.
• W2565328088 hasConceptScore W2565328088C1491633281 @default.
• W2565328088 hasConceptScore W2565328088C185592680 @default.
• W2565328088 hasConceptScore W2565328088C190283241 @default.
• W2565328088 hasConceptScore W2565328088C2776277131 @default.
• W2565328088 hasConceptScore W2565328088C2776415932 @default.
• W2565328088 hasConceptScore W2565328088C2780783641 @default.
• W2565328088 hasConceptScore W2565328088C2781018059 @default.
• W2565328088 hasConceptScore W2565328088C29537977 @default.
• W2565328088 hasConceptScore W2565328088C502942594 @default.

• next